文献速递眼底病与葡萄膜炎角膜与眼表疾病神经眼科

减重术后维生素A缺乏的患病率、眼部表现及治疗反应:系统综述与荟萃分析

Prevalence, Ocular Manifestations, and Treatment Response in Postbariatric Vitamin A Deficiency: A Systematic Review and Meta-Analysis.
PubMed 文献 · Am J Ophthalmol · 2026-09-24

该系统综述与荟萃分析评估减重手术后生化维生素A缺乏的术式特异性患病率,并汇总眼部表现、术后潜伏期及维生素A补充反应。结果显示不同术式患病率差异明显,RYGB术后为18.0%,BPD术后为59.0%,RYGB妊娠期达63.3%;眼部症状出现可晚至术后数年至数十年,多数治疗后可改善或缓解。

要点

  • 减重术后维生素A缺乏呈术式特异性,RYGB术后18.0%,BPD术后59.0%,BPD-DS术后37.8%。
  • RYGB妊娠期维生素A缺乏患病率达63.3%(95%CI 43.9-80.1)。
  • 14例可评估眼部治疗结局中13例(93%)改善或缓解。

核心结论

  • 在有充分数据的术式中,维生素A缺乏呈术式特异性,RYGB妊娠期常见。
  • 减重术后眼部病变可在术后数年至数十年出现,但识别并治疗缺乏后常改善。
  • 减重术后患者出现夜盲、眼表疾病、非典型外层视网膜表现或不明原因视力下降时应检测血清视黄醇。

研究设计与样本

  • 遵循PROSPERO注册(CRD420261329094),系统检索MEDLINE、Embase、Cochrane CENTRAL、Scopus和Web of Science至2026年3月。
  • 初筛1574篇摘要,纳入27篇报告(代表21项独立研究),其中18项提供定量数据。
  • 9项非妊娠监测队列(455名受检者)进入患病率荟萃分析。
  • 采用Cochrane RoB 2、ROBINS-I和JBI清单评估偏倚风险,采用GRADE框架评估证据确定性。

主要发现

  • RYGB术后维生素A缺乏患病率为18.0%,BPD术后为59.0%,BPD-DS术后为37.8%,JIB术后为42.5%。
  • 上述异质术式及研究定义视黄醇阈值合并估计为26.1%(95%CI 18.5-35.4),作为次要汇总报告。
  • RYGB妊娠期特异性患病率为63.3%(95%CI 43.9-80.1)。
  • 在有症状分母的活动性/正式非重叠队列中,夜盲患病率为60.1%。
  • 眼部表现中位潜伏期:RYGB术后5年,BPD-DS、JIB或修正手术后14至27年(19例患者)。

关键数值与推荐

  • 14例有可评估眼部结局的减重术后治疗反应记录中,13例(93%)改善或缓解。
  • 证据确定性受异质性、部分术式亚组队列少及眼部结局选择性报告限制。

临床怎么用

  • 眼科医生应认识减重术后维生素A缺乏的术式特异性风险,尤其RYGB妊娠期。
  • 对减重术后出现夜盲、眼表疾病、非典型外层视网膜表现或不明原因视力下降者,应检测血清视黄醇。
  • 识别维生素A缺乏后及时补充,多数眼部病变可改善或缓解。

局限性

  • 异质性限制证据确定性。
  • 部分术式亚组的队列数量少。
  • 眼部结局存在选择性报告。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

TOPIC: To estimate procedure-specific prevalence of biochemical vitamin A deficiency after bariatric surgery and synthesize ocular manifestations, postoperative latency, and response to vitamin A repletion. CLINICAL RELEVANCE: As bariatric surgery volume continues to rise, recognition of procedure-specific vitamin A deficiency and its ocular manifestations may improve ophthalmic surveillance, earlier diagnosis, and timely repletion in postbariatric patients. METHODS: Following PROSPERO registration (CRD420261329094), we did a systematic review of MEDLINE, Embase, the Cochrane Central Register of Controlled Trials, Scopus, and Web of Science through March 2026 for studies reporting vitamin A status or ocular manifestations after bariatric surgery. Risk of bias was evaluated with the Cochrane RoB 2, Risk of Bias in Nonrandomized Studies of Interventions, and Joanna Briggs Institute checklists; the overall certainty of evidence was assessed with the Grading of Recommendations, Assessment, Development, and Evaluation framework. RESULTS: Of 1574 abstracts screened, 27 reports representing 21 unique studies met inclusion criteria; 18 contributed quantitative data, of which 9 nonpregnancy surveillance cohorts (455 tested participants) entered the prevalence meta-analysis. Prevalence was 18.0% after Roux-en-Y gastric bypass (RYGB), 59.0% after biliopancreatic diversion (BPD), 37.8% after BPD with duodenal switch, and 42.5% after jejunoileal bypass; the pooled estimate across these heterogeneous procedures and study-defined retinol thresholds was 26.1% (95% CI, 18.5-35.4), reported as a secondary summary. Pregnancy-specific post-RYGB prevalence was 63.3% (95% CI, 43.9-80.1). Night blindness prevalence was 60.1% in active/formal nonoverlapping cohorts with symptom denominators. Median latency to ocular presentation was 5 years after RYGB and 14 to 27 years after BPD with duodenal switch, jejunoileal bypass, or revisional procedures (19 patients). Among 14 postbariatric treatment-response records with assessable ocular outcomes, 13 (93%) improved or resolved. CONCLUSION: Among the procedures with adequate data, vitamin A deficiency is procedure-specific and common during pregnancy after RYGB. Ocular disease may present years to decades after surgery but often improves when deficiency is recognized and treated. Certainty was limited by heterogeneity, the small number of cohorts for some procedure subgroups, and selective reporting of ocular outcomes. Nyctalopia, ocular surface disease, atypical outer retinal findings, or unexplained visual decline in a postbariatric patient warrant serum retinol testing.

来源:Am J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Abdel-Sayyed A, Bigam S, Alizada A, et al. Prevalence, Ocular Manifestations, and Treatment Response in Postbariatric Vitamin A Deficiency: A Systematic Review and Meta-Analysis. Am J Ophthalmol. 2026. PMID: 42785498. doi:10.1016/j.ajo.2026.09.026

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。